Key result
Cardiac Miro1 knockout in mice increases mitochondrial density ~13% and drives cardiac dysfunction.
Why the study?
Neuronal Miro1 regulates mitochondrial movement, but the role of cardiac Miro1 remains poorly understood.
Loss of the mitochondrial protein Miro1 drives aberrant mitochondrial remodeling and cardiac dysfunction, highlighting a potential mechanistic link and therapeutic target in type 2 diabetes-linked heart failure.
Answers are grounded in this paper and cite their sources.
Miro1 knockout data should not yet inform clinical HF management; leaves open its validation as a target in diabetic cardiomyopathy.
Cardiac mitochondrial remodelling is a hallmark of type 2 diabetes-linked heart failure (T2DM-HF). We previously reported that mitochondrial morphological changes occur in early-stage disease and identified down-regulation of the mitochondrial protein Miro1 (Rhot1). Neuronal Miro1 regulates mitochondrial movement but the role of cardiac Miro1 remains poorly understood. Therefore, we generated a cardiac-specific Miro1 knockout (Miro1 cko ) mouse model to investigate how cardiomyocyte-Miro1 deficiency affects cardiac and mitochondrial structure-function. Miro1 cko mice compared to controls develop mild diastolic and systolic dysfunction and electrical abnormalities, cellular hypertrophy and fibrosis. Miro1 cko leads to aberrant mitochondrial respiration and elevated H₂O₂ production, consistent with electron microscopy showing disrupted cristae morphology, with putative links to Myosin19 down-regulation. Three-dimensional electron microscopy identified mitochondrial remodelling with interfibrillar mitochondria (IFM) ~50% smaller with an increased surface complexity. Since fusion-fission protein expression was unchanged these data identify Miro1 as a regulator of mitochondrial morphology. Mitochondrial density increases (34% Miro1 cko ; 30% control), with abnormal IFM clustering, which we suggest is associated with impaired mitophagy since PINK1 and Parkin are down-regulated (~80% and ~ 60% respectively) and imaging flow cytometry of isolated primary cardiomyocytes identified an ~2-fold reduction to mitochondrial clearance indicative of blunted mitophagy. Heterozygous knockout mice, which display a milder cardiac phenotype, rapidly developed HF symptoms when given a high fat diet with L-NAME. In conclusion, loss of Miro1 drives multiple aberrant mitochondrial remodelling events culminating in cardiac dysfunction and predisposes towards accelerated metabolic-HF development. Loss of Miro1 may represent a critical mechanistic link in T2DM-HF pathogenesis and therefore a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Kassab et al. (2026) studied Type 2 diabetes-linked heart failure. Cardiac-specific Miro1 knockout vs. Controls was evaluated on Mitochondrial density. Cardiac-specific Miro1 knockout in mice drove aberrant mitochondrial remodelling, increasing mitochondrial density and culminating in cardiac dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: